The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Metabolic Myopathies
Abstract
PURPOSE OF REVIEW: Metabolic myopathies are genetic disorders that impair intermediary metabolism in skeletal muscle. Impairments in glycolysis/glycogenolysis (glycogen-storage disease), fatty acid transport and oxidation (fatty acid oxidation defects), and the mitochondrial respiratory chain (mitochondrial myopathies) represent the majority of known defects. The purpose of this review is to develop a diagnostic and treatment algorithm for the metabolic myopathies. RECENT FINDINGS: The metabolic myopathies can present in the neonatal and infant period as part of more systemic involvement with hypotonia, hypoglycemia, and encephalopathy; however, most cases present in childhood or in adulthood with exercise intolerance (often with rhabdomyolysis) and weakness. The glycogen-storage diseases present during brief bouts of high-intensity exercise, whereas fatty acid oxidation defects and mitochondrial myopathies present during a long-duration/low-intensity endurance-type activity or during fasting or another metabolically stressful event (eg, surgery, fever). The clinical examination is often normal between acute events, and evaluation involves exercise testing, blood testing (creatine kinase, acylcarnitine profile, lactate, amino acids), urine organic acids (ketones, dicarboxylic acids, 3-methylglutaconic acid), muscle biopsy (histology, ultrastructure, enzyme testing), MRI/spectroscopy, and targeted or untargeted genetic testing. SUMMARY: Accurate and early identification of metabolic myopathies can lead to therapeutic interventions with lifestyle and nutritional modification, cofactor treatment, and rapid treatment of rhabdomyolysis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accordingly, premature fatigue (i.e. a faster drop in force) related to decreased mitochondrial oxidative capacity has been shown to precede overt muscle weakness in mouse models with mitochondrial dysfunction, as well as in patients with mitochondrial myopathies (Finsterer, 2020; Tarnopolsky, 2016; Yamada et al., 2012).”
From Impaired aerobic capacity and premature fatigue preceding muscle weakness in the skeletal muscle Tfam-knockout mouse model (2021) · cites this paper as Tarnopolsky, 2016
Citations
Cites
Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies
Holt, I. J., Harding, A. E., & Morgan-Hughes, J. A. (1988) · Nature · doi:10.1038/331717a0 · Cited by 1,846
Thompson, P. D., Clarkson, P., & Karas, R. H. (2003) · JAMA · doi:10.1001/jama.289.13.1681 · Cited by 1,463
Effects of Purifying and Adaptive Selection on Regional Variation in Human mtDNA
Ruiz-Pesini, E., Mishmar, D., Brandon, M., Procaccio, V., & Wallace, D. C. (2004) · Science · doi:10.1126/science.1088434 · Cited by 806
Parikh, S., Goldstein, A., Koenig, M. K., Scaglia, F., Enns, G. M., Saneto, R., Anselm, I., Cohen, B. H., Falk, M. J., Greene, C., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.177 · Cited by 607
Self-citationMYOPATHY DUE TO A DEFECT IN MUSCLE GLYCOGEN BREAKDOWN
(1951) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1951.tb74724.x · Cited by 596
A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy.
Klopstock, T., Yu-Wai-Man, P., Dimitriadis, K., Rouleau, J., Heck, S., Bailie, M., Atawan, A., Chattopadhyay, S., Schubert, M., Garip, A., et al. (2011) · Brain · doi:10.1093/brain/awr170 · Cited by 578
Disorders of carnitine transport and the carnitine cycle
Longo, N., Amat di San Filippo, C., & Pasquali, M. (2006) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.30087 · Cited by 543
AAEM minimonograph #26: The electrodiagnosis of carpal tunnel syndrome
Stevens, J. C. (1997) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199712)20:12 · Cited by 518
Self-citationArnold, D. L., Matthews, P. M., & Radda, G. K. (1984) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910010303 · Cited by 442
Exercise Intolerance Due to Mutations in the Cytochrome b Gene of Mitochondrial DNA
Andreu, A. L., Hanna, M. G., Reichmann, H., Bruno, C., Penn, A. S., Tanji, K., Pallotti, F., Iwata, S., Bonilla, E., Lach, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411404 · Cited by 431
Research works printed but not linked: 1
- Tarnopolsky MA Roy BD MacDonald JR. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 1997;20(12):1502–1509. doi:10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C. · DOI · Paper page
Cited by
Skeletal muscle: molecular structure, myogenesis, biological functions, and diseases
Feng, L., Chen, Z., & Bian, H. (2024) · MedComm · doi:10.1002/mco2.649 · Cited by 120
He, N., & Ye, H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1792-1_17 · Cited by 52
Bleeker, J. C., Visser, G., Clarke, K., Ferdinandusse, S., de Haan, F. H., Houtkooper, R. H., IJlst, L., Kok, I. L., Langeveld, M., van der Pol, W. L., et al. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12217 · Cited by 43
Update review about metabolic myopathies
Finsterer, J. (2020) · Life · doi:10.3390/life10040043 · Cited by 31
Metabolic Myopathies in the Era of Next-Generation Sequencing
Urtizberea, J. A., Severa, G., & Malfatti, E. (2023) · Genes · doi:10.3390/genes14050954 · Cited by 30
Metadata
- Authors
- Tarnopolsky, M. A.
- Corresponding author
- Tarnopolsky, Mark A.
- ORCID
- Tarnopolsky, Mark A.
- Venue
- Continuum
- Published
- 2016-12
- Volume
- 22
- Issue
- 6
- Pages
- 1829-1851
- ISSN
- 1080-2371 (ISSN-L)
- 1538-6899
- OpenAlex
- W4245914306
- Cited by
- 61
- References
- 91
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 12 · 2023: 7 · 2022: 12 · 2021: 5 · 2020: 6 · 2019: 7 · 2018: 2 · 2017: 2 · 2016: 1
- FWCI
- 3.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CONTINUUM Lifelong Learning in Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- metabolic myopathies, skeletal muscle metabolism, glycogen storage disease, fatty acid oxidation disorders, mitochondrial myopathy, exercise intolerance, rhabdomyolysis, diagnostic algorithm, acylcarnitine profile, urinary organic acids, muscle biopsy, creatine kinase, hypoglycemia, hypotonia, genetic testing
- MeSH terms
- Female, Glycogen Storage Disease Type V, Glycogen Storage Disease Type VII, Humans, Male, Metabolism, Inborn Errors, Middle Aged, Muscular Diseases, Rhabdomyolysis, Mitochondrial Myopathies, Glycogenolysis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolic Myopathies. https://app.cochat.ai/papers/10.1212/con.0000000000000403
- The paper
- Tarnopolsky, M. A. (2016). Metabolic Myopathies. Continuum. https://doi.org/10.1212/con.0000000000000403
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.